Stock Picks Today: ITC Hotels, Tata Consumer, Paytm, Sona BLW, And More On Brokerages' Radar

Brokerages have highlighted opportunities across hospitality, FMCG, real estate, pharma, fintech, telecom, consumer services, capital goods and consumer durables sector issuing fresh calls on ITC Hotels, Tata Consumer Products, One 97 Communications, Sona BLW, Urban Company, Mankind Pharma, KEI Industries, Aditya Birla Real Estate, Sheela Foam, Bharti Hexacom, Vodafone Idea while also sharing their outlook on auto and defence sector.

Jefferies on ITC Hotels

• Maintain Buy; Hike TP to Rs 220 from Rs 210
• Sharp Beat, Mirroring Strong Sector Trends
• RevPAR rose 21%, mirroring strong sector trends, while mgmt fees grew 25% YoY
• Targets 10% key CAGR over FY26-31
• Raise EBITDA by ~3-5%; Attractive Valuations.

Investec on ITC Hotels

• Maintain Buy with TP of Rs 201
• RevPAR gains and margin expansion drive earnings beat
• Strong pricing and occupancy gains drive growth
• Operating leverage supports earnings beat

Jefferies on Tata Consumer

• Maintain Buy; Cut TP to Rs 1250 from Rs 1450
• Growth Portfolio Riding the quick commerce Wave
• Preferred Staple Picks
• Q2 was ahead despite inflationary pressures in tea/salt
• Product price hikes should help ahead
• International saw a revenue decline but saw margin expansion
• FY27 guidance of 50-70bps YoY EBITDA margin expansion stays.

Citi on Tata Consumer

• Maintain Buy; Cut TP to Rs 1225 from Rs 1400
• Growth Momentum Sustained; Sequential Margin Recovery Ahead
• See a clearer margin recovery path through H2
• Pricing actions across multiple categories  are yet to flow through fully
• This should help mitigate India margin pressures
• Stronger international and non-branded profitability provide further support at the consolidated level
• Estimate 50 bps of EBITDA margin expansion in H2.

ALSO READ | Stock Market Today: All You Need To Know Going Into Trade On Oct 27

Jefferies on Sona BLW

• Maintain Buy; Hike TP to Rs 950 from Rs 900
• Q2 Beat and Good Order Traction
• Secured new orders across differentials, radar sensors and motors & motor controllers
• Recent partnership with Denso and entry into robotics & physical AI has also opened up big opportunities
• Valuation is rich, but multiples should sustain given strong engineering capabilities and growth potential.

Kotak Securities on Sona BLW

• Maintain Sell; Hike TP to Rs 700 from Rs 675
• Healthy topline performance; Q2 EBITDA 9.5% above expectations
• Sona Comstar 2.0 outlines the next phase of growth
• Partnership with DENSO across 2W/3W and 4W/CV EV and hybrid powertrains
• Valuation remains expensive, which drives SELL rating

Citi on Sona BLW

• Maintain Buy; Hike TP to Rs 960 from Rs 830
• Strong Beat Driven By Healthy Revenue Growth
• Demand Outlook Robust But Cost Headwinds Persist
• Order book trends and product-commercialisation trends are healthy
• Margins are likely to remain under pressure given severe material cost inflation, increase in freight rates, and mix shift towards 2W traction motors

GS on Sona BLW

• Maintain Neutral; Hike TP to Rs 860 from Rs 855
• Q2 beat: EV traction + suspension motors to lead growth H2 growth
• See improving momentum in the EV traction motor and suspension motor business
• Although this comes at a more modest margin

BofA on Urban Company

• Maintain Underperform with TP of Rs 150
• Focusing on right levers; Traction strong across segments
• Steady Core business, InstaHelp burn may be high in near term
• InstaHelp to remain in deliberate burn to win the category
• India core: Flywheel intact; Salon Now opens a use case
• In planned AC foray, the company would remain capex light & asset light
• This is in partnership with Amber, in addition to Native water purifier.

UBS on Urban Company

• Maintain Buy with TP of Rs 180
• Densification breeds a step change in growth trajectory
• Conclusion from Analyst Day: See upside risk to Rs 1000 cr EBITDA guidance by FY31
• Operating leverage is coming through despite higher marketing investments
• Fundraise provides strategic flexibility to pursue inorganic opportunities over next 2-3 years
• Fundraise is building relative balance sheet strength while signalling willingness to compete aggressively in InstaHelp
• Current cash balance is not expected to come under stress through the expected Q3FY28 breakeven.

Jefferies on Mankind Pharma

• Maintain Buy; Cut TP to Rs 2900 from Rs 3220
• No Longer Waiting for Godot
• Q2 results beat; strong Q2 was driven by robust domestic growth and solid export momentum
• This resulted in gross margin gains and operating leverage
• Domestic formulations grew 16% YoY, finally outpacing industry growth
• Muted consumer healthcare growth was the only weak point in Q2
• An improving growth outlook drives 3% Ebitda increase for FY27-29.

Kotak Securities on Mankind Pharma

• Maintain Buy with TP of Rs 3035
• Organic growth shifts into a higher gear
• From 10% YoY in Q1, organic domestic growth accelerates to 14%+ YoY in Q2
• BSV maintains strong momentum; bake in 20% sales CAGR over FY26-29

Jefferies on Paytm

• Maintain Buy with TP of Rs 2150
• Q2: Momentum Stays Strong; MDR To Aid Profit & Investments
• Sharp rise in Ebitda margin to 10% led by efficiencies
• PBT was 17% above est., but PAT (pre-exceptional) was in line due to higher taxes
• Rev growth is led by financial services (loan distribution, investments)
• UPI-MDR will start post-Diwali & mgt sees 2.5bps on GMV as revenues
• See strong growth continuing & stays in 25% Cagr Club

Citi on Paytm

• Maintain Buy; Hike TP to Rs 1940 from Rs 1560
• Solid Growth and Margins Uptick Ahead of MDR Slingshot
• Seeing growth acceleration in financial services and improvement in net payment margins even ex-UPI
• Upping investments in tech (AI), marketing and distribution (MTU acquisition, on-ground sales-fleet)
• EBITDA beat estimates owing to higher share of financial services revenue.

Kotak Securities on Defence

• Rs 2.1 lakh cr of approvals reflect a shift to unmanned and air-defense capabilities
• ~82% of the proposed procurement value is earmarked for domestic industry
• Marks the largest DAC approval of FY27 so far and nearly doubles FYTD Acceptance of Necessity to Rs 3.7 lakh cr
• Unlike the land-mobility-heavy September package, this tranche is skewed toward unmanned systems, counter-UAS, short-range air defense and helicopters, alongside major indigenous naval platforms
• BEL has the widest multi-item exposure
• Hindustan Aeronautics gains from two helicopter programs
• Bharat Dynamics from VSHORADS and IAF weapons, and the drone ecosystem
• Order accrual from this tranche will largely fall in FY2028-30E. 

ALSO READ | Five Stocks To Buy Today, October 27: Dr Reddy's Laboratories, Asahi India Glass, Ajanta Pharma, And More

Also Read | Layoffs Are Rising In Tech, But These Skills Are Helping People Unlock Better Pay

Citi on Bharti Hexacom

• Upgrade to Buy from Neutral; Hike TP to Rs 1870 from Rs 1700
• Superior growth warrants premium valuation
• A cleaner way to play India telecom growth
• Gov't stake sale an overhang, but also a potential clearing event
• Shift preference to Hexacom over Airtel among the telcos

Jefferies on Vodafone Idea

• Maintain Buy; Cut TP to Rs 16 from Rs 20
• Attractive risk-reward
• Stock has corrected 23% despite improving subscriber trends
• Ongoing network rollouts, along with tariff hikes, should position VodaIdea well to deliver 11%/25% CAGRs in revenue/EBITDA over FY26-29
• At 21x EV/cash EBITDA, shares trades below 5-yr average multiples
• See 25% potential downside and 143% potential upside in bear and bull scenario.

UBS on Auto

• Festive update: Tractors outperform cars in festive; MHCVs tracking double digit growth
• Festive demand continues to grind lower - 2Ws +11%; cars -9%
• Base gets tougher from now on
•  Channel check points to low single digit decline in tractors so far
•  2W market share: Hero/Bajaj tracking 90bps/80bps decline vs. 110bps gains for TVS
• Cars: M&M market share increases by 240bps.

Investec on Sheela Foam

• Upgrade to Hold from Sell; Cut TP to Rs 625 from Rs 700
• Recent price correction has made valuation more reasonable
• See 20% EPS CAGR over FY27-29
• Bake in conservative revenue growth of 7% CAGR over FY26-29, average EBITDA margin at 9.7%
• Issues - input-cost pressures, demand sensitivity to pricing, downtrading risks and competition from D2C mattresses with lower TDI and polyol content

JPMorgan on KEI Industries

• Upgrade to Overweight from Neutral; Cut TP to Rs 4650 from Rs 5650
• Volume growth pickup ahead
• Risk/reward favorable after margin expectation reset
• Product mix shift could protect margins

Jefferies on AB Real Estate

• Maintain Buy; Cut TP to Rs 1600 from Rs 1880
• Reported strong P&L in Q2 on a project delivery, with non-core asset sale proceeds helping turn the balance sheet nearly net cash
• New project additions have picked up pace, though same will likely get launched from late FY27 onwards
• Management focusing on long term value maximisation
• Delay in Worli launch would impact near term pre-sales even as commercial buildout gains visibility
• Stock trades at 45% NAV discount.

Disclaimer: The views and opinions expressed by the investment advisers on NDTV Profit are of their own and not of NDTV Profit. NDTV Profit advises users to consult with their own financial or investment adviser before taking any investment decision.
 

Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.